Two years ago, doctors told Janusz Racz he had months to live. A golf-ball-sized tumor, inoperable Stage 3 lung cancer, despite no symptoms at all.
The 69-year-old retired computer scientist enrolled in a U.K. clinical trial and became the first person there to receive an #mRNA cancer vaccine. After a year of treatment, the cancer was gone.
Stories like his are why #mRNA research can't stall now. Read more: https://t.co/UMIktKM5co
One year ago, @HHSGov abruptly terminated $500M in #mRNA vaccine research, claiming the data showed it didn't work.
In the year since, the FDA approved Moderna's mRNA flu vaccine, which was 26.6% more effective than standard shots in trials. Meanwhile, mRNA treatments for deadly forms of cancer and rare disease are demonstrating remarkable results.
The data was never the problem.
A major milestone.
The FDA has approved the first mRNA influenza vaccine, expanding the same vaccine platform first used against COVID.
A reminder that even as this scientific milestone is being celebrated, this administration has dismantled large parts of the US mRNA research ecosystem through funding cuts, canceled programs, and workforce reductions.
Last night, the FDA approved a new #mRNA vaccine from @moderna_tx.
This comes exactly one year after @HHSGov canceled nearly $500 million in mRNA research funding.
mRNA research is critical to not only preventing disease but delivering new treatments for life-threatening conditions like cancer. Today's approval shows why continued investment matters.
Today, the @US_FDA is expected to make a final decision on @moderna_tx’s first-of-its-kind mRNA flu vaccine.
#mRNA has already helped save millions of lives, and a green light today would mean more lives protected by science that keeps delivering.
With the FDA expected to make a final decision on this flu vaccine on Wednesday, it’s a reminder that regulatory predictability and stability is essential to our industry and advancing the future of medicine.
Hear more from Jeff: https://t.co/97lM1pnwYq
In February, the @US_FDA refused to even review Moderna's #mRNA flu vaccine, before reversing course a week later.
As AMM Co-founder and Executive Committee Member Jeff Coller recently shared with @NPR, this had a chilling effect across the mRNA ecosystem, which is predominantly made up of smaller companies.
Read more in the @AndObserver about how South Carolina’s growing Life Sciences sector – including promising mRNA research – is bringing new hope to patients: https://t.co/L8gD3IFPTZ
Global leadership in #mRNA medicine takes sustained investment – like the Department of Defense's funding of #mRNA research to protect American warfighters from deadly diseases abroad.
Keeping that lead matters at home too. It's how we protect patient health and make sure America isn't relying on other countries for the next breakthrough treatments.
Learn more: https://t.co/rJcwd84Sif
Today’s Senate hearing is fueling a fresh round of mRNA questions.
Despite what you may hear, mRNA vaccines have saved millions of lives and are among the most widely tested medical technologies in history.
Decades of rigorous research have shown #mRNA medicines and therapies to be safe and effective.
Scientists continue to monitor for long-term adverse effects, just as they do for any medicine.
Learn more: https://t.co/JMVorIzymT
An op-ed in the @DCExaminer made an important point: Beyond infectious diseases, #mRNA could be the next breakthrough in cancer care and is viewed by national security experts as a possible first line of defense against biological threats.
Other countries have taken notice, too. Roughly half of new #mRNA vaccines now in development worldwide originate in China.
Now, in 2026, that same technology just revealed another surprise: scientists discovered a hidden backup immune pathway that could make #mRNA cancer vaccines even more effective.
Learn more: https://t.co/TFW1SDlDIm
New from @reason: with 13 billion #mRNA vaccine doses administered worldwide, a major safety review found they are:
🩺 87% effective at preventing infection
🏥 93% at preventing hospitalization
💊 94% at preventing death from COVID-19
Serious side effects remain rare, and this confirms what six years of research have consistently shown: mRNA technology is safe and effective.
Learn more: https://t.co/UcTJw0EwuA
With vaccine-preventable illness costing U.S. manufacturers roughly $30 billion a year, a new @ShopFloorNAM report makes clear: evidence-based policymaking is critical to the American economy.
Predictable policy and regulation is also essential for the growing #mRNA industry, which is bringing hope and better health for Americans and patients worldwide.
Read the report: https://t.co/a9UGzcCkcr